Abstract
Background: Laryngopharyngeal reflux (LPR) disease is an extraesophageal manifestation of gastroesophageal reflux disease (GERD). The impact of GERD-related LPR on the psychological well-being and quality of life (QOL) in Chinese is not known. Aim: To assess the QOL in patients with LPR disease. Methods: 76 LPR and 73 healthy subjects were recruited. Psychological well-being was assessed by the Hospital Anxiety and Depression Score and QOL was assessed by SF-36. Results: 51/76 (67.1%) patients had GERD-related LPR. More LPR subjects had taken sick leave (36.2 vs. 5.6%, p = 0.001) and reported adverse social life impact (60.5 vs. 38.9%, p = 0.013). LPR patients showed significantly worse results on the Voice Handicap Index (47.8 vs. 7.6, p = 0.001), were more anxious and had worse QOL in social functioning, pain and general health perception domains of SF-36. GERD-related LPR subjects had a higher depression score (4.8 vs. 3.8, p = 0.014) and a lower mental summary score (41.8 vs. 48.4, p = 0.01) in SF-36 compared with those without GERD. Conclusions: LPR had a negative impact on psychological status, social functioning and QOL. GERD symptoms appeared to be the main contributor to decrease QOL. GERD-related LPR patients had a significant impact on the mental component of their QOL.
Journal Section:
Original Paper
References
1.
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–1920.
[PubMed]
2.
Joniau S, Bradshaw A, Esterman A, Carney AS: Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg 2007;136:686–692.
[PubMed]
3.
Khan AM, Hashmi SR, Elahi F, Tariq M, Ingrams DR: Laryngopharyngeal reflux: a literature review. Surgeon 2006;4:221–225.
[PubMed]
4.
Wong WM, Lam KF, Cheng C, Hui WM, Xia HH, Lai KC, Hu WH, Huang JQ, Lam CL, Chan CK, Chan AO, Lam SK, Wong BC: Population-based study of non-cardiac chest pain in Southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol 2004;10:707–712.
[PubMed]
5.
Wong WM, Lai KC, Lau CP, Hu WH, Chen WH, Wong BC, Hui WM, Wong YH, Xia HH, Lam SK: Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment Pharmacol Ther 2002;16:465–471.
[PubMed]
6.
Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, Xia HH, Huang JQ, Chan CK, Lam SK, Wong BC: Prevalence, clinical spectrum and health care utilization of gastroesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2003;18:595–604.
[PubMed]
7.
Wong WM, Lai KC, Hui WM, Lam KF, Huang JQ, Hu WH, Wong NY, Lam CL, Xia HH, Chan AO, Lam SK, Wong BC: Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-hour oesophageal and intragastric pH in Chinese subjects with gastroesophageal reflux disease. Aliment Pharmacol Ther 2004;19:455–462.
[PubMed]
8.
Wong WM, Lam KF, Lai KC, Hui WM, Hu WH, Lam CL, Wong NY, Xia HH, Huang JQ, Chan AO, Lam SK, Wong BC: A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastroesophageal reflux disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1407–1413.
[PubMed]
9.
Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS, Newman CW: The Voice Handicap Index: development and validation. Am J Speech Lang Pathol 1997;6:66–70.
10.
Ware JE Jr, Keller SD, Gandek B, Brazier JE, Sullivan M: Evaluating translations of health status questionnaires. Methods from the IQOLA project. International quality of life assessment. Int J Technol Assess Health Care 1995;11:525–551.
[PubMed]
11.
Lam CL, Gandek B, Ren XS, Chan MS: Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey. J Clin Epidemiol 1998;51:1139–1147.
[PubMed]
12.
Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–370.
13.
Lam CL, Tse EY, Gandek B: Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res 2005;14:539–547.
[PubMed]
14.
Leung CM, Ho S, Kan CS, Hung CH, Chen CN: Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale. A cross-cultural perspective. Int J Psychosom 1993;40:29–34.
[PubMed]
15.
Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL: The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004;114:670–674.
[PubMed]
16.
Siupsinskiene N, Adamonis K, Toohill RJ: Quality of life in laryngopharyngeal reflux patients. Laryngoscope 2007;117:480–484.
[PubMed]
17.
Ali Mel S: Laryngopharyngeal reflux: diagnosis and treatment of a controversial disease. Curr Opin Allergy Clin Immunol 2008;8:28–33.
[PubMed]
18.
Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1–78.
[PubMed]
19.
Koufman JA, Aviv JE, Casiano RR, Shaw GY: Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32–35.
[PubMed]
20.
Wong WM, Lam SK, Hui WM, Lai KC, Chan CK, Hu WH, Xia HH, Hui CK, Yuen MF, Chan AO, Wong BC: Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese – prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002;16:2037–2042.
[PubMed]
21.
Branski RC, Bhattacharyya N, Shapiro J: The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002;112:1019–1024.
[PubMed]
22.
Hill RK, Simpson CB, Velazquez R, Larson N: Pachydermia is not diagnostic of active laryngopharyngeal reflux disease. Laryngoscope 2004;114:1557–1561.
[PubMed]
23.
Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the reflux finding score. Laryngoscope 2001;111:1313–1317.
[PubMed]
© 2009 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2008
You do not currently have access to this content.
